DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$17.88
+0.32 (+1.82%)
As of Mar 24, 1:30 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target +447.3% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $17.88
Current
$17.88
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
328.7%
Low target
Base Case
$97.86
+447.3%
Avg target
Bull Case
$132.93
+643.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$25.00
-28.5% from high
52-Week Low
$6.36
+181.1% from low
50-Day SMA
$18.16
-1.5% vs SMA
200-Day SMA
$14.91
+19.9% vs SMA
RSI (14)
28.7
Oversold
Target vs 52W High
$97.86
+291.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%